Synergistic effect of prolactin on IFN-gamma-mediated growth arrest in human monoblastic cells: correlation with the up-regulation of IFN-gamma receptor gene expression

Immunol Lett. 1996 Nov;53(2-3):125-30. doi: 10.1016/s0165-2478(96)02622-3.

Abstract

Interferon-gamma (IFN-gamma) stimulates the development of monocytic features in human myeloid precursors. Because transcriptional regulation of IFN-gamma and the pituitary hormone prolactin (PRL) has been described to involve common Jak-STAT pathways, we addressed here the question of whether PRL plays a role in monoblastic (U937) cell growth and macrophage maturation. In contrast to IFN-gamma, PRL did not affect U937 cell growth nor induction of differentiation as assessed by the unchanged cell surface expression of maturation markers CD11b and HLA-DR class II. However, PRL in synergy with IFN-gamma inhibited, in a time- and dose-dependence, proliferation of U937 cells without influencing their maturation induced by IFN-gamma. IFN-gamma and PRL both affected the expression of the IFN-gamma receptor (IFN-gamma R) gene by increasing IFN-gamma R mRNA levels. The rise in IFN-gamma R transcripts was accompanied by a low but significant release of IL-6 which has previously been shown to stabilize IFN-gamma R mRNA. Moreover, a transient increase in surface expression of IFN-gamma R was observed in U937 cells treated by IFN-gamma alone or in combination with PRL, whereas no apparent modulation of cell surface IFN-gamma R was observed in cells treated with PRL. Lastly, PRL did not induce transcriptional activation in IFN-gamma inducible IRF-1 and Fc gamma RI genes in U937 cells. Together, our data indicate that IL-6 secretion and increased expression of the IFN-gamma R gene correlate with U937 cell growth arrest induced by IFN-gamma and PRL, probably through a signaling mechanism which does not involve the Stat 1/IRF-1 pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Northern
  • Cell Division / drug effects
  • Cells, Cultured
  • DNA-Binding Proteins / genetics
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Flow Cytometry
  • HLA-DR Antigens / biosynthesis
  • Humans
  • Interferon Regulatory Factor-1
  • Interferon-gamma / pharmacology*
  • Interleukin-1 / metabolism
  • Interleukin-6 / metabolism
  • Macrophage Activation / drug effects*
  • Macrophage-1 Antigen / biosynthesis
  • Monocytes / drug effects*
  • Monocytes / metabolism*
  • Phosphoproteins / genetics
  • Prolactin / pharmacology*
  • RNA, Messenger / metabolism
  • Receptors, IgG / genetics
  • Receptors, Interferon / genetics
  • Receptors, Interferon / metabolism
  • Time Factors
  • Transcription, Genetic / drug effects

Substances

  • DNA-Binding Proteins
  • HLA-DR Antigens
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Interleukin-1
  • Interleukin-6
  • Macrophage-1 Antigen
  • Phosphoproteins
  • RNA, Messenger
  • Receptors, IgG
  • Receptors, Interferon
  • Interferon-gamma
  • Prolactin